Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03678181 · ClinicalTrials.gov registry record · NA
Increasing Engagement and Improving HIV Outcomes Via HealthMPowerment
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 750
- Enrollment target
NCT03678181: Completed NA study, sponsored by University of Pennsylvania.
NCT03678181 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 750 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03678181, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 750 participants
- Enrollment target
Study Summary
The overall goal of this 3-arm randomized trial is to test whether a network-driven online intervention tailored for intersectional stigma amelioration can elicit online social support, promote intervention engagement, and mitigate the impact of multiple stigmas on HIV-related outcomes among young Black and/or Latino men who have sex with men and transgender women.
Primary Outcome
The investigators will estimate the proportion of participants who test at least twice for HIV over a 12-month period by intervention group.
Interventions
- BEHAVIORAL Social Support
- BEHAVIORAL Information Resources
- BEHAVIORAL HIV Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2020-07-07 |
| Est. Completion | 2023-10-15 |
| Phase | NA |
What the finished NCT03678181 record still lists
NCT03678181 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 3 interventions - of which Social Support is the first listed.
NCT03678181 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03678181 about?
NCT03678181 is a clinical study titled "Increasing Engagement and Improving HIV Outcomes Via HealthMPowerment". The overall goal of this 3-arm randomized trial is to test whether a network-driven online intervention tailored for intersectional stigma amelioration can elicit online social support, promote intervention engagement, and mitigate the impact of multiple stigmas on HIV-related outcomes among young B...
What is the current status of trial NCT03678181?
This trial is currently completed. It is a NA study. The enrollment target is 750 participants. The study started on 2020-07-07. Estimated completion is 2023-10-15.
What interventions are being tested in trial NCT03678181?
The interventions under investigation include: Social Support (BEHAVIORAL), Information Resources (BEHAVIORAL), HIV Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT03678181?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03678181's enrollment target sits among peer trials
750 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI